Zobrazeno 1 - 10 of 20 pro vyhledávání: '"L. Kosse"'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
2
Immune-mediated inflammatory disease patients’ preferences in adverse drug reaction information regarding biologics
Autor: Eugène van Puijenbroek, Frank Hoentjen, Phyllis I. Spuls, Martijn B. A. van Doorn, Bart J F van den Bemt, Michael T. Nurmohamed, G. Weits, L. Kosse, Naomi T Jessurun, Harald E. Vonkeman, Sander W. Tas
Publikováno v: Expert Opinion on Drug Safety, 19, 8, pp. 1049-1054
Expert Opinion on Drug Safety, 19(8), 1049-1054. Taylor & Francis Ltd
Expert opinion on drug safety, 19(8), 1049-1054. Taylor & Francis
Kosse, L J, Weits, G, Vonkeman, H E, Spuls, P I, Van Den Bemt, B J F, Tas, S W, Hoentjen, F, Nurmohamed, M T, Van Doorn, M B A, Van Puijenbroek, E P & Jessurun, N T 2020, ' Immune-mediated inflammatory disease patients' preferences in adverse drug reaction information regarding biologics ', Expert opinion on drug safety, vol. 19, no. 8, pp. 1049-1054 . https://doi.org/10.1080/14740338.2020.1781090
Expert Opinion on Drug Safety, 19, 1049-1054
Expert opinion on drug safety, 19(8), 1049-1054. Taylor and Francis Ltd.
Expert opinion on drug safety, 1-5. Taylor and Francis Ltd.
STARTPAGE=1;ENDPAGE=5;ISSN=1474-0338;TITLE=Expert opinion on drug safety
OBJECTIVES: Patient-reported outcomes (PROs) are increasingly used in studies and medical practice to obtain information on patients' perspectives toward their treatment or disease. However, most study outcomes are primarily directed at healthcare pr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d526eba6c4953f10dc4074834d38b923
https://doi.org/10.1080/14740338.2020.1781090
Zobrazit plný text záznamu
3
Patients with inflammatory rheumatic diseases
Autor: Michael T. Nurmohamed, Karin M Spijkers, Bart J F van den Bemt, Victor J. B. Huiskes, Naomi T Jessurun, L. Kosse, Renske C. F. Hebing
Publikováno v: Kosse, L J, Jessurun, N T, Hebing, R C F, Huiskes, V J B, Spijkers, K M, van den Bemt, B J F & Nurmohamed, M T 2020, ' Patients with inflammatory rheumatic diseases : quality of self-reported medical information in a prospective cohort event monitoring system ', Rheumatology (Oxford, England), vol. 59, no. 6, pp. 1253-1261 . https://doi.org/10.1093/rheumatology/kez412
Rheumatology (Oxford, England), 59(6), 1253-1261. Oxford University Press
Rheumatology, 59, 1253-1261
Rheumatology, 59, 6, pp. 1253-1261
Objectives Assessment of the quality of patient-reported medical information in the Dutch Biologic Monitor and evaluation of the representativeness of the sampled participants. Methods Consecutive adult patients using a biologic DMARD (bDMARD) for an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::802d946bdc902c09d99ab295ad543994
http://www.scopus.com/inward/record.url?scp=85085264370&partnerID=8YFLogxK
Zobrazit plný text záznamu
4
Stakeholders’ perspectives on a patient-reported outcome measure-based drug safety monitoring system for immune-mediated inflammatory diseases
Autor: Naomi T Jessurun, Harald E. Vonkeman, Martijn B. A. van Doorn, Eugène van Puijenbroek, Marieke de Vries, Michael T. Nurmohamed, L. Kosse, Bart J F van den Bemt, Frank Hoentjen, Sander W. Tas
Publikováno v: Kosse, L J, Jessurun, N T, Vonkeman, H E, Tas, S W, Nurmohamed, M T, Hoentjen, F, van Doorn, M B A, van Puijenbroek, E P, van den Bemt, B J F & de Vries, M 2020, ' Stakeholders’ perspectives on a patient-reported outcome measure-based drug safety monitoring system for immune-mediated inflammatory diseases ', Expert opinion on drug safety, vol. 19, no. 11, pp. 1521-1528 . https://doi.org/10.1080/14740338.2020.1803826
Expert Opinion on Drug Safety, 19, 11, pp. 1521-1528
Expert opinion on drug safety, 19(11), 1521-1528. Taylor and Francis Ltd.
Expert Opinion on Drug Safety, 19(11), 1521-1528. Taylor & Francis Ltd
Expert Opinion on Drug Safety, 19, 1521-1528
Expert opinion on drug safety, 19(11), 1521-1528. Taylor & Francis
Contains fulltext : 221677.pdf (Author’s version postprint ) (Open Access) Contains fulltext : 221677pub.pdf (Publisher’s version ) (Open Access) Background: Biologics are used as effective therapeutics to treat a variety of diseases. Even though
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c99f610ca252052d282bf6797f958bb0
https://doi.org/10.1080/14740338.2020.1803826
Zobrazit plný text záznamu
5
Patients’ perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomes
Autor: Sander W. Tas, Phyllis I. Spuls, Geert R. D'Haens, L. Kosse, Frank Hoentjen, Michael T. Nurmohamed, Bart J F van den Bemt, Martijn B. A. van Doorn, Eugène van Puijenbroek, G. Weits, Naomi T Jessurun, Harald E. Vonkeman
Publikováno v: Kosse, L J, Weits, G, Vonkeman, H E, Tas, S W, Hoentjen, F, van Doorn, M B A, Spuls, P I, D’Haens, G R, Nurmohamed, M T, van Puijenbroek, E P, van den Bemt, B J F & Jessurun, N T 2021, ' Patients’ perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomes ', Expert opinion on drug safety, vol. 20, no. 12, pp. 1565-1572 . https://doi.org/10.1080/14740338.2021.1963436
Expert Opinion on Drug Safety, 20(12), 1565-1572. Taylor & Francis Ltd
Expert Opinion on Drug Safety, 20, 12, pp. 1565-1572
Expert opinion on drug safety, 20(12), 1565-1572. Taylor & Francis
Expert Opinion on Drug Safety, 20, 1565-1572
Expert opinion on drug safety, 20(12), 1565-1572. Taylor and Francis Ltd.
Contains fulltext : 244669.pdf (Publisher’s version ) (Closed access) BACKGROUND: Patient-reported outcomes (PROs) on adverse drug reactions (ADRs) are increasingly used in cohort event monitoring (CEM) to obtain a better understanding of patients'
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6899aae39d458b1b5b87c5e79cea6f14
https://research.vumc.nl/en/publications/b0e4eaca-4bdc-4310-b3e0-d7d35d2d36d7
Zobrazit plný text záznamu
6
POS1532-HPR SEX DIFFERENCES IN THE EXPERIENCED BURDEN OF ADVERSE DRUG REACTIONS ATTRIBUTED TO ADALIMUMAB AND ETANERCEPT BY PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES
Autor: H. Gosselt, J. Van Lint, L. Kosse, S. Tas, P. Spuls, H. Vonkeman, M. Nurmohamed, M. Van Doorn, B. Van den Bemt, N. Jessurun
Publikováno v: Annals of the Rheumatic Diseases. 81:1111.1-1111
BackgroundPatients experience burden of adverse drug reactions.1 So far, it is not known whether men and women experience adverse drug reactions (ADRs) with the same burden.ObjectivesTo examine sex differences in regard to the burden of mutually repo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a91a7fd6e1279f9181e7dcc0bcc8b453
https://doi.org/10.1136/annrheumdis-2022-eular.2787
Zobrazit plný text záznamu
7
Inflammatory bowel disease patients provide reliable self-reported medical information: A multicentre prospective pharmacovigilance monitoring system
Autor: L. Kosse, Pepijn W. A. Thomas, Rachel L. West, Tessa E H Römkens, Naomi T Jessurun, Ibdream registry, Jeroen M. Jansen, Maurice G. Russel, Frank Hoentjen
Publikováno v: Pharmacoepidemiology and Drug Safety
Pharmacoepidemiology and Drug Safety, 30, 520-524
Pharmacoepidemiology and Drug Safety, 30, 4, pp. 520-524
Contains fulltext : 235646.pdf (Publisher’s version ) (Open Access) PURPOSE: To assess the agreement between patient-reported and health care provider-reported medical information in inflammatory bowel disease (IBD). METHODS: This multicentre, pros
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6730d2c42f87025a9294cad1215040a8
https://pubmed.ncbi.nlm.nih.gov/33219593
Zobrazit plný text záznamu
8
SAT0149 EVALUATION OF A PROSPECTIVE COHORT EVENT MONITORING MODEL FOR PATIENT-REPORTED ADVERSE DRUG REACTIONSATTRIBUTED TO BIOLOGICAL DMARDS: VALIDITY OF THE PATIENT-REPORTED INFORMATION AND REPRESENTATIVENESS OF THE PARTICIPANTS
Autor: Victor J. B. Huiskes, L. Kosse, Naomi T Jessurun, Karin M Spijkers, Renske C. F. Hebing, Michael T. Nurmohamed
Publikováno v: SATURDAY, 15 JUNE 2019.
Background: To gain knowledge on the prevalence, course and treatment of adverse drug reactions (ADRs) attributed to biological DMARDs (bDMARDs) and the experienced impact of ADRs on patients, an ADR-focused online questionnaire system was developed
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2b7c3faabcf94beee0b0de05946b9738
https://doi.org/10.1136/annrheumdis-2019-eular.5324
Zobrazit plný text záznamu
9
AB0196 SURVIVAL ANALYSIS OF TIME TO FIRST ADVERSE DRUG REACTION AND DRUG SURVIVAL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB AND ETANERCEPT
Autor: P.M. ten Klooster, Naomi T Jessurun, Harald E. Vonkeman, J. Jansen, Joep H G Scholl, K. Velthuis, M. Nguyen, L. Kosse
Publikováno v: Annals of the Rheumatic Diseases. 80:1122.1-1122
Background:Treatment of rheumatoid arthritis (RA) with biologic disease-modifying antirheumatic drugs (bDMARDs) has been common practice in the last two decades. However, differences in patients experiencing adverse drug reactions (ADRs) between indi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::14f1e35839d5e8dce7024af0f3c927f9
https://doi.org/10.1136/annrheumdis-2021-eular.179
Zobrazit plný text záznamu
10
POS0271-HPR PATIENT PERSPECTIVE ON A DRUG SAFETY MONITORING SYSTEM FOR IMMUNE-MEDIATED INFLAMMATORY DISEASES BASED ON PATIENT-REPORTED OUTCOMES
Autor: Geert R. D'Haens, B. van den Bemt, Phyllis I. Spuls, Frank Hoentjen, Naomi T Jessurun, Harald E. Vonkeman, G. Weits, E P van Puijenbroek, Michael T. Nurmohamed, Sander W. Tas, L. Kosse, M.B.A. van Doorn
Publikováno v: Annals of the Rheumatic Diseases. 80:359.2-359
Background:Patient-reported outcomes (PROs) on adverse drug reactions (ADRs) are increasingly used in cohort event monitoring (CEM) to obtain a better understanding of patient’s real-world experience with drugs. Despite the leading role for patient
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::11c0f7a64d5dbd66a992f4e589e98211
https://doi.org/10.1136/annrheumdis-2021-eular.635
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje